Skip to main content

Table 5 EORTC QLQ-C30 symptom scores by clinical characteristics of gynaecological cancer patients at TASH, Addis Ababa, Ethiopia, 2014(n = 140)

From: Health related quality of life of gynaecologic cancer patients attending at Tikur Anbesa Specialized Hospital (TASH), Addis Ababa, Ethiopia

Variables

Fatigue

Nausea &

vomiting

Pain

Dyspnea

Insomnia

Diarrhea

Financial difficulties

constipation

Appetite loss

Parity

0

25.92(±15.18)

5.56(±13.61)

33.33(±14.91)

16.67(±27.89)

16.67(27.89)

0.00(±0.00)

27.78(±32.78)

11.11(±27.22)

38.89(±38.97)

1-4

48.69(±29.36)

6.74(15.01)

47.87(±29.20)

5.67(±17.47)

31.91(36.08)

1.41(±6.80)

58.87(±33.48)

37.58(±39.69)

32.62(36.44)

5-9

59.68(±26.77)

10.71(±21.43)

61.43(28.31)

7.14(±18.73)

39.99(±31.90)

1.43(±8.86)

72.38(±28.36)

50.48(±36.66)

55.24(±34.46)

≥10

54.90(±30.30)

2.94(±6.55)

56.86(±33.88)

3.92(±11.07)

39.21(±33.82)

0.00(±0.00)

62.74(±35.12)

49.01(±44.28)

31.37(±34.33)

P value

0.015

0.35

0.024

0.49

0.28

0.87

0.003

0.05

0.003

Stage

Stage 1

32.41(±26.58)

9.72 ± 28.83)

33.34(±22.47)

2.78(±9.62)

25.00 ± 28.87

0.00 ± 0.00

55.55 ± 38.49

22.22 ± 41.03

22.22 ± 38.48

Stage 2

49.43(±24.33)

3.40(±8.32)

50.68(±26.78)

4.08(±12.97)

27.89 ± 29.93

0.68 ± 4.76

67.35 ± 30.80

33.33 ± 34.70

36.06 ± 31.80

Stage 3 and 4

66.07 ± 28.70

8.93 ± 19.846

70.54 ± 27.34

7.14 ± 19.81

49.41 ± 35.39

1.78 ± 9.89

70.24 ± 28.20

63.69 ± 36.11

51.19 ± 37.05

P-value

<0.001*

0.219

<0.001*

0.536

0.002*

0.649

0.320

<0.001*

0.013*

Cancer type

Cervical, vaginal vulvar

55.95 ± 29.11

5.51 ± 14.91

58.78 ± 29.17

4.46 ± 15.17

37.80 ± 34.51

0.89 ± 7.02

67.56 ± 30.50

46.73 ± 39.13

41.96 ± 36.00

Ovarian

53.97 ± 20.87

24.60 ± 25.61

46.83 ± 26.15

20.64 ± 26.83

33.33 ± 27.89

3.17 ± 10.03

58.73 ± 36.37

39.68 ± 40.30

61.91 ± 33.81

Endometrial

22.22 ± 22.22

2.38 ± 6.30

21.43 ± 23.00

0.00 ± 0.00

19.05 ± 32.53

0.00 ± 00.00

38.10 ± 40.50

19.05 ± 26.23

23.81 ± 41.79

P value

0.009*

0.000*

0.002*

0.000*

0.330

0.394

0.042*

0.161

0.023*

  1. Independent t test (for two groups comparison) and one way ANOVA (for three and above group comparison) were employed,,* significant at p-value less than 0.05